New Merck cancer drug wins FDA approval
Thursday, September 4, 2014 - 18:00
in Health & Medicine
Brooks HaysWASHINGTON, Sept. 4 (UPI) -- Melanoma, the deadliest form of skin cancer, has a new adversary in Keytruda, a new drug from pharmaceutical stalwart Merck & Co.